Dr. Holms Discusses Ezrin Peptide Therapy & its Potential for Long COVID | Interview

2 years ago
96

Join The Conversation! | https://trialsitenews.com/

Dr. Rupert Holms earned his doctoral degree in molecular biology, is the inventor of Ezrin Peptide Pharmaceuticals and is CEO of NewalR&D Ltd, a London-based company that is developing a peptide treatment for Long COVID. You can learn more about his research here:

https://www.mdpi.com/2673-5601/2/3/33

Loading comments...